Remy Durand's Insider Trades & SAST Disclosures
Remy Durand's most recent trade in Alpine Immune Sciences Inc was a trade of 112,500 Stock Option (Right to buy) done . Disclosure was reported to the exchange on May 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Remy Durand.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 112,500 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 109,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 102,192 | 31,200 (0%) | 0% | - | Common Stock | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 78,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 70,155 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 31,200 | 0 (0%) | 0% | - | Common Stock | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 26,922 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 2,635 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 38,078 | 26,922 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.23 per share. | 08 May 2024 | 38,078 | 123,392 (0%) | 0% | 3.2 | 122,992 | Common Stock |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 25,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.51 per share. | 08 May 2024 | 25,000 | 72,949 (0%) | 0% | 6.5 | 162,750 | Common Stock |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 08 May 2024 | 12,365 | 85,314 (0%) | 0% | 4.1 | 50,573 | Common Stock |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 12,365 | 2,635 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.76 per share. | 08 May 2024 | 10,000 | 133,392 (0%) | 0% | 4.8 | 47,600 | Common Stock |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 9,845 | 70,155 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.20 per share. | 08 May 2024 | 9,845 | 47,949 (0%) | 0% | 13.2 | 129,954 | Common Stock |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 78,000 | 78,000 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Remy Durand | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 31,200 | 38,104 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges